Skip to content

The Impact of Leg Immobilization on Postabsorptive and Postprandial Muscle Protein Breakdown in Healthy Young Males

The Impact of Leg Immobilization on Postabsorptive and Postprandial Muscle Protein Breakdown in Healthy Young Males

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03934632
Enrollment
24
Registered
2019-05-02
Start date
2019-04-15
Completion date
2023-01-09
Last updated
2023-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

The present study will seek the quantify the simultaneous muscle protein synthesis and breakdown response with and without amino acid provision in humans following 2 days of immobilisation.

Interventions

OTHERPostabsorptive

Saline will be infused to mimic postabsorptive circulating amino acid concentrations

An amino acid infusate will be administered to mimic postprandial circulating amino acid concentrations

One leg will undergo 2 days immobilisation prior to the test day

Sponsors

University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Male * 18-40 years of age * Body mass index between 18.5 and 30

Exclusion criteria

* Any diagnosed metabolic impairment (e.g. type 1 or 2 Diabetes) * Any diagnosed cardiovascular disease (e.g. deep vein thrombosis) or hypertension * Chronic use of any prescribed or over the counter pharmaceuticals (that may modulate muscle protein metabolism) * A personal or family history of epilepsy, seizures or schizophrenia * Any known disorders in muscle metabolism * Regular use of nutritional supplements * Allergy to lidocaine * Allergy to one or multiple amino acids * Recent (within the last 6 months) or current musculoskeletal injury (e.g. leg fracture) as these could be exacerbated by the intervention e.g. unilateral leg immobilisation, or mean the participant is unable to use crutches. * Having received or ingested a stable isotope tracer in the past

Design outcomes

Primary

MeasureTime frameDescription
Muscle protein breakdown rate1 hourMuscle protein breakdown rate (FBR, measured in %/h) during 1 hour of saline or amino acid infusion

Secondary

MeasureTime frameDescription
Muscle protein breakdown rate3 hoursMuscle protein breakdown rate (FBR, measured in %/h) during 3 hours of saline or amino acid infusion
Muscle protein synthesis rate3 hoursMuscle protein synthesis rate (FSR, measured in %/h) during 3 hours of saline or amino acid infusion measured using a D5 phenylalanine infusion

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026